Singapore markets open in 5 hours 18 minutes

Gilead Sciences, Inc. (GILD)

NasdaqGS - NasdaqGS Real-time price. Currency in USD
Add to watchlist
66.20-0.01 (-0.02%)
As of 03:42PM EDT. Market open.
Full screen
Trade prices are not sourced from all markets
Previous close66.21
Bid66.16 x 800
Ask66.16 x 900
Day's range65.65 - 66.42
52-week range57.17 - 74.12
Avg. volume7,001,598
Market cap82.979B
Beta (5Y monthly)0.35
PE ratio (TTM)20.24
Earnings dateN/A
Forward dividend & yield2.92 (4.41%)
Ex-dividend date14 Sept 2022
1y target estN/A
  • Editor's pick
    Yahoo Finance Video

    Nasdaq 100 surges ahead of this week's retail earnings

    Yahoo Finance's Jared Blikre takes a look at how the Nasdaq 100 and major sectors are performing into the close.

  • Zacks

    Gilead (GILD) Announces Positive Data on Breast Cancer Drug

    Gilead (GILD) breast cancer drug Trodelvy improves overall survival in pre-treated HR+/HER2- metastatic breast cancer patients. The company will also acquire the remaining rights to the drug.

  • Motley Fool

    Why Gilead Sciences Stock Was a 5% Winner Today

    Gilead Sciences (NASDAQ: GILD) stock was off to a good start this week, rising by more than 5% on Monday against the modest (0.4%) gain of the S&P 500 index. The prominent pharmaceutical company had some good news to impart about an important cancer drug. Gilead announced that morning that its breast cancer treatment Trodelvy recorded "statistically significant and clinically meaningful" results in a phase 3 clinical trial.